Replies to post #105953 on Biotech Values

[RockRat]

>> did TEVA specify that it was the t-enoxaparin facility (or facilties) that was/were inspected, or simply the heparin feedstock facilites that had been inspected? <<

I asked for both, and the answer seemed to be both.

Regards, RockRat